LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹3,540 Cr | ₹3,112 Cr | ₹2,432 Cr | ₹2,681 Cr | ₹2,457 Cr |
What is the latest Total Current Liabilities ratio of LAURUS LABS ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹3,540 Cr |
Mar2024 | ₹3,112 Cr |
Mar2023 | ₹2,432 Cr |
Mar2022 | ₹2,681 Cr |
Mar2021 | ₹2,457 Cr |
How is Total Current Liabilities of LAURUS LABS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹3,540 Cr | 13.73 | |
Mar2024 | ₹3,112 Cr | 27.96 | |
Mar2023 | ₹2,432 Cr | -9.28 | |
Mar2022 | ₹2,681 Cr | 9.11 | |
Mar2021 | ₹2,457 Cr | - |
Compare Total Current Liabilities of peers of LAURUS LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LAURUS LABS | ₹47,753.4 Cr | 6.5% | 7% | 101.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,192.0 Cr | 0.3% | -4% | -6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,479.0 Cr | 2% | -9.6% | 33.1% | Stock Analytics | |
CIPLA | ₹125,113.0 Cr | 1.9% | 4.5% | -0.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,539.0 Cr | 0.6% | 3.6% | 9.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,926.0 Cr | 2% | -1% | -7% | Stock Analytics |
LAURUS LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LAURUS LABS | 6.5% |
7% |
101.2% |
SENSEX | 1.3% |
-0.8% |
3.2% |
You may also like the below Video Courses